3M/Cemax-Icon deal bears fruit at AHRA show

Article

PACS firms 3M and Cemax-Icon displayed one of the first resultsof their new relationship at this month's American HealthcareRadiology Administrators meeting in Nashville. The companies introducedCemax-Icon ArchiveManager 2.0, a new software product that

PACS firms 3M and Cemax-Icon displayed one of the first resultsof their new relationship at this month's American HealthcareRadiology Administrators meeting in Nashville. The companies introducedCemax-Icon ArchiveManager 2.0, a new software product that useshierarchical storage management (HSM) to manage images for archivingmedia, including optical jukeboxes, tape jukeboxes and RAID (redundantarray of inexpensive disks) systems.

3M provided the software and data-storage media for ArchiveManagerwhile Cemax-Icon developed the application interface. Cemax-Iconwill market the software, which is compatible with its line ofPACS products and which supports the DICOM 3.0 and HL7 standards.3M made an equity investment in Cemax-Icon in June (SCAN 6/21/95).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.